(ii) For Alzheimer’s disease characterized by the presence of amyloid β-polypeptide (Aβs), Actovegin can effectively mediate the inflammatory pathway caused by Aβs by increasing oxidative activation, which can improve cell apoptosis and protect the nervous system. This evidence concerns the gene DDX41 and Alzheimer disease.